Psoriasis is an autoimmune disease that causes skin plaques. Psoriasis is now known as a systemic inflammatory disease, despite the fact that it was once believed to be limited to the skin. Recently, there has been a greater understanding of the risk of heart disease associated with psoriasis. On the surface, psoriasis, a bothersome skin condition, seems to have little in common with heart disease. Despite this, evidence from around the world suggests the two conditions are related in some way.

Why does this happen?

Psoriasis is a skin condition that causes inflammation both on the surface and within the body. Long-term inflammation in the body can damage your heart and blood vessels, increasing your chances of getting heart disease or having a stroke. According to study findings, people with extreme psoriasis are more likely to be affected. Mild psoriasis appears to have little effect on the risk.

Over a 10-year period, people with serious psoriasis were 54 percent more likely to have a stroke, 21% more likely to have a heart attack, and 53% more likely to die than people without the skin disease. They were also more likely to need an angioplasty operation to clear clogged heart arteries. People with psoriasis should seek treatment for their symptoms as well as be tested for heart disease risk factors and make lifestyle improvements to reduce their risk of potential cardiovascular issues, such as maintaining a healthy weight.

Psoriasis is not only linked to a higher prevalence of cardiovascular risk factors, but it is also a risk factor in and of itself for the development of cardiovascular disease. Current guidelines concentrate solely on established risk factors, ignoring psoriasis as a separate risk factor. To uncover the necessary measures of heart disease associated with psoriasis beyond traditional risk reduction and identification of early cardiovascular disease in psoriasis patients, as well as to establish a cardiovascular disease prevention regimen, an interdisciplinary approach is required.